Antitubercular activity of α,ω-diaminoalkanes, H2N(CH2)nNH2

Bioorganic and Medicinal Chemistry Letters

Volumn 19, Issue 17, 2009, Pages 4937-4938

  Vergara, Fátima M F ^a   Henriques, Maria das G M O ^a   Candea, André L P ^a   Wardell, Jim L ^a   De Souza, Marcus V N ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Diamines; Drugs; Ethambutol; Tuberculosis

Indexed keywords

ALPHA OMEGA DIAMINOALKANE DERIVATIVE; DIAMINE DERIVATIVE; ETHAMBUTOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ALKANES; ANIMALS; ANTITUBERCULAR AGENTS; CELL LINE; ETHAMBUTOL; MICE; MYCOBACTERIUM TUBERCULOSIS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

MYCOBACTERIUM TUBERCULOSIS;

EID: 68549089180     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2009.07.086     Document Type: Article

References (16)

1. De Souza M.V.N., Ferreira M.L., Pinheiro A.C., Saraiva M.F., Almeida M.V., and Valle M.S. Sci. World J. 8 (2008) 720
2. Faria A.F., De Souza M.V.N., Bruns R.E., and De Oliveira M.A.L. J. Chromatogr. 1202 (2008) 224
3. De Souza M.V.N. Curr. Curr. Opin. Pulm. Med. 12 (2006) 167
4. De Souza M.V.N. Recent Patents Anti-Infective Drug Discovery 1 (2006) 33
5. Protopopova M., Hanrahan C., Nikonenko B., Samala R., Chen P., Gearhardt J., Einck L., and Nacy C.A. J. Antimicrob. Chemother. 56 (2005) 968
6. Bogatcheva E., Hanrahan C., Nikonenko B., Samala R., Chen P., Gearhart J., Barbosa F., Einck L., Nacy C.A., and Protopopova M. J. Med. Chem. 49 (2006) 3045
7. Faugeroux V., Genisson Y., Salma Y., Constant P., and Baltas B. Bioorg. Med. Chem. 15 (2007) 5866
8. Yendapally R., and Lee R.E. Bioorg. Med. Chem. 18 (2008) 1607
9. Canetti J., Rist E., and Grosset R. Rev. Tuberc. Pneumol. 27 (1963) 217
10. Franzblau S.G., Witzig R.S., McLaughlin J.C., Torres P., Madico G., and Hernandez A. J. Clin. Microbiol. 36 (1998) 362
11. 2, n = 2-12) was made directly on the plate. The final drug concentrations tested were 0.01-10.0 μL/mL. Plates were covered and sealed with parafilm and incubated at 37 °C for five days. After this time, 25 μL of a freshly prepared 1:1 mixture of Alamar Blue (Accumed International, Westlake Ohio) reagent and 10% tween 80 was added to the plate and incubated for 24 h. A blue color in the well was interpreted as no bacterial growth, and a pink color was scored as growth. The MIC (Minimal Inhibition Concentration) was defined as the lowest drug concentration, which prevented a color change from blue to pink.
12. Vanitha J.D., and Paramasivan C.N. Mycobacteriology 49 (2004) 179
13. Reis R.S., Neves Jr. I., Lourenço S.L.S., Fonseca L.S., and Lourenço M.C.S. J. Clin. Microbiol. 42 (2004) 2247
14. Souza M.C., Siani A.C., Ramos M.F.S., Limas O.M., and Henriques M.G.M.O. Pharmazie 58 (2003) 582
15. Carvalho M.V., Penido C., Siani A.C., Valente L.M.M., and Henriques M.G.M.O. Inflammo Pharmacol. 14 (2006) 48
16. 6 UFC/well/100 μL) cultured in the presence of medium alone, tween 20 (3%) (live and dead controls, respectively) or different concentrations of compounds (1.0, 10.0 and 100 μg/mL) in a triplicate assay. After 48 h, stock MTT solution (5 mg/mL of saline; 20 mL/well) was added to the culture and 4 h later, the plate was centrifugate for 2 min at 2800 rpm, supernatant was discharged and Dimethyl sulfoxide (DMSO) (100 μL/well) was added for formazan crystals solubilization and the absorbance was read at 540 nm in a plate reader (Biorad-450).